documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

4 rows where docket_id = "FDA-2017-D-6146" and posted_year = 2020 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 1

  • 2020 · 4 ✖

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2017-D-6146-0008 FDA None FDA-2017-D-6146 Footnote 13- Junqueira Adipose Chapter 6 re: Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use; Guidance for Industry and Food and Drug Administration Staff; Availability Supporting & Related Material Background Material 2020-07-21T04:00:00Z 2020 7     2020-07-21T16:40:31Z   0 0 090000648478bf67
FDA-2017-D-6146-0006 FDA None FDA-2017-D-6146 Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use; Guidance for Industry and Food and Drug Administration Staff; Availability Notice Notice of Availability 2020-07-21T04:00:00Z 2020 7 2020-07-21T04:00:00Z   2020-07-21T16:11:13Z 2020-15718 0 0 090000648478b72b
FDA-2017-D-6146-0009 FDA None FDA-2017-D-6146 Footnote 14 - Adipose Stem Cells Science Review 2010 re: Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use; Guidance for Industry and Food and Drug Administration Staff; Availability Supporting & Related Material Background Material 2020-07-21T04:00:00Z 2020 7     2020-07-21T16:40:47Z   0 0 090000648478bf68
FDA-2017-D-6146-0007 FDA None FDA-2017-D-6146 Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use; Guidance for Industry and Food and Drug Administration Staff; Availability Other Guidance 2020-07-21T04:00:00Z 2020 7 2020-07-21T04:00:00Z   2024-11-06T23:38:25Z   1 0 090000648478bf65

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;